The plasma kallikrein-kinin system: its evolution from contact activation

Area of Science:

• Biochemistry
• Physiology
• Cell Biology

Background:

• The plasma kallikrein-kinin system, comprising factor XII (FXII), prekallikrein (PK), and high molecular weight kininogen, was historically viewed as a surface-activated coagulation pathway.
• Its in vivo activation during tissue damage or thrombosis is known, but its precise physiological role remains incompletely understood.

Purpose of the Study:

• To investigate novel pathways for prekallikrein (PK) activation.
• To elucidate the physiological functions of the kallikrein-kinin system beyond coagulation.

Main Methods:

• Exploration of cellular proteolytic pathways for PK activation.
• Analysis of FXII-independent PK activation mechanisms.
• Assessment of the system's role in blood pressure regulation, thrombosis, and cellular processes.

Main Results:

• Identification of a cell-associated proteolytic pathway for PK activation that is independent of factor XII (FXII).
• Demonstration that this pathway leads to subsequent FXII activation, indicating distinct physiological roles.
• Evidence linking the system to blood pressure regulation and thrombosis risk modulation, separate from hemostasis.
• Findings suggest involvement in endothelial cell proliferation, angiogenesis, and apoptosis via cellular signaling.

Conclusions:

• The understanding of the plasma kallikrein-kinin system has evolved beyond its initial characterization as a coagulation initiator.
• A cell-based, FXII-independent pathway for PK activation governs critical physiological processes.
• This system plays significant roles in cardiovascular regulation and cellular dynamics, independent of traditional hemostasis.